eduardotrachtenbergeduardotrachtenberg Facebook ad: “Um dos medicamentos com previsão de chegada ao…”
Ran for 30 days, from May 12 to June 10, 2026, the last day Crush saw it.
Run by eduardotrachtenberg on Instagram. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 773239175756076
- Platforms
- Relaunches
- 0
Ad text
Um dos medicamentos com previsão de chegada ao BR nos próximos anos Durgam S, Earley WR, Kozauer SG, et al. Lumateperone as adjunctive therapy in patients with major depressive disorder: results from a randomized, double-blind, phase 3 trial. J Clin Psychiatry 2025.i Calabrese JR, Durgam S, Satlin A, et al. Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. Am Jour Pyschiatry 2021.
